5 Apr

As ageing populations face increasing mobility challenges due to joint and bone deterioration, exciting new health solutions are also emerging. At the 2017 World Congress of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) last month, Peptan presented scientific evidence from preclinical investigations on how collagen peptides improve the bone health.

As ageing populations face increasing mobility challenges due to joint and bone deterioration, exciting new health solutions are also emerging. At the 2017 World Congress of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) last month, Peptan presented scientific evidence from preclinical investigations on how collagen peptides improve bone health. 

The WCO-IOF-ESCEO, which took place from March 23-26 in Florence, Italy, is the world’s leading clinical conference on bone, joint and muscle health. As the global market leader in collagen peptides and one of the conference’s official sponsors, Peptan is an active advocate of nutrition-based solutions to mobility challenges faced by the elderly. 

Shifting the balance towards ‘bone building’

At the March event, Peptan presented a poster1 outlining the mechanisms of action behind the benefits of collagen peptides for bone health. The poster drew from evidence gained in a preclinical investigation, in which Peptan supplementation enabled mice with induced osteoporosis (ovariectomized mice) to maintain healthy bones. Subsequent cell studies revealed that Peptan collagen peptides can modulate the activities of key bone cell populations – so-called osteoblasts and osteoclasts- thereby shifting the balance towards ‘bone building’. The research was carried out by Peptan’s R&D and Nutritional scientists in collaboration with the French National Institute for Agricultural Research (INRA), one of the leading academic institutes in the field of food and nutrition. Researchers from the University of Nantes and the Paris Descartes University also contributed.

Raising global awareness 

The WCO-IOF-ESCEO conference targets healthcare professionals, researchers and young scientists. Last year’s event attracted nearly 4,000 participants eager to keep in step with the latest developments in bone, joint and muscle health. This was the second year in a row in which Peptan contributed to the event. Participating in the conference is an expression of Peptan’s commitment to raising global awareness regarding the prevention, diagnosis and treatment of osteoporosis. 

Discover more on the science behind Peptan and its benefits for mobility

Reference

1. Daneault A, Prawitt J, Coxam V, Guicheux J, Rochefort G-Y, Wittrant Y (2017) Hydrolyzed collagen promotes bone health in ovariectomized mice through the modulation of both the osteoblast and osteoclast activities. Osteoporos Int 28: Supplement 1, P389